NO986056L - Faste orale doseringsformer av valsartan - Google Patents

Faste orale doseringsformer av valsartan

Info

Publication number: NO986056L
Authority: NO; Norway
Prior art keywords: valsartan; dosage forms; oral dosage; solid oral; solid
Prior art date: 1996-06-27

Application number

NO986056A

Other languages

English (en)

Other versions

NO317181B1 (no

NO986056D0 (no

Inventor

Robert Frank Wagner

Yoshimitsu Katakuse

Takashi Taike

Fujiki Yamato

Manfred Kohlmeyer

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-27

Filing date

1998-12-22

Publication date

1998-12-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO986056(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-12-22 Application filed by Novartis Ag filed Critical Novartis Ag

1998-12-22 Publication of NO986056D0 publication Critical patent/NO986056D0/no

1998-12-22 Publication of NO986056L publication Critical patent/NO986056L/no

2004-09-06 Publication of NO317181B1 publication Critical patent/NO317181B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO19986056A 1996-06-27 1998-12-22 Faste orale doseringsformer av valsartan NO317181B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9613470.5A GB9613470D0 (en)	1996-06-27	1996-06-27	Small solid oral dosage form
PCT/EP1997/003172 WO1997049394A2 (en)	1996-06-27	1997-06-18	Sold oral dosage forms of valsartan

Publications (3)

Publication Number	Publication Date
NO986056D0 NO986056D0 (no)	1998-12-22
NO986056L true NO986056L (no)	1998-12-22
NO317181B1 NO317181B1 (no)	2004-09-06

Family

ID=10795969

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19986056A NO317181B1 (no)	1996-06-27	1998-12-22	Faste orale doseringsformer av valsartan
NO20041287A NO331739B1 (no)	1996-06-27	2004-03-26	Komprimerte, faste orale doseringsformer av valsartan og hydroklortiazid

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20041287A NO331739B1 (no)	1996-06-27	2004-03-26	Komprimerte, faste orale doseringsformer av valsartan og hydroklortiazid

Country Status (33)

Country	Link
US (3)	US6294197B1 (no)
EP (7)	EP1767207A3 (no)
JP (5)	JP2000506540A (no)
KR (6)	KR101161283B1 (no)
CN (3)	CN1475207B (no)
AR (2)	AR008618A1 (no)
AT (3)	ATE371449T1 (no)
BR (1)	BR9709956A (no)
CA (2)	CA2259148C (no)
CO (1)	CO4870755A1 (no)
CY (1)	CY2553B1 (no)
CZ (1)	CZ296850B6 (no)
DE (3)	DE69739642D1 (no)
DK (3)	DK1410797T3 (no)
ES (3)	ES2290400T3 (no)
GB (1)	GB9613470D0 (no)
HK (2)	HK1019858A1 (no)
HU (1)	HU229134B1 (no)
ID (1)	ID17553A (no)
IL (2)	IL127564A0 (no)
MY (3)	MY156312A (no)
NO (2)	NO317181B1 (no)
NZ (2)	NZ333385A (no)
PE (1)	PE87498A1 (no)
PL (2)	PL188271B1 (no)
PT (3)	PT1767206E (no)
RU (5)	RU2203054C2 (no)
SI (2)	SI0914119T1 (no)
SK (1)	SK285902B6 (no)
TR (1)	TR199802698T2 (no)
TW (1)	TW473394B (no)
WO (1)	WO1997049394A2 (no)
ZA (1)	ZA975673B (no)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9613470D0 (en) *	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
US20030045561A1 (en) *	2001-02-06	2003-03-06	Smithkline Beecham Corporation	Method of treating isolated systolic hypertension
IL137979A0 (en) *	1998-03-04	2001-10-31	Takeda Chemical Industries Ltd	Production, release preparation for aii antagonist-sustained and use thereof
ATE348601T1 (de)	1998-05-18	2007-01-15	Takeda Pharmaceutical	Im munde zerfallende tablette enthaltend ein benzimidazole
CN1733307A (zh) *	1998-07-10	2006-02-15	诺瓦提斯公司	缬沙坦和钙通道阻断剂的抗超敏组合
CN1636561A (zh) *	1998-12-23	2005-07-13	诺瓦提斯公司	At－1受体拮抗剂在治疗与at－1受体增加有关的疾病中的应用
PL197161B1 (pl) *	1999-01-26	2008-03-31	Novartis Ag	Zastosowanie antagonistów receptora angiotensyny II
CN101011390A (zh)	1999-01-26	2007-08-08	诺瓦提斯公司	血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
JP2003507418A (ja) *	1999-08-24	2003-02-25	メディキュアインターナショナルインコーポレイテッド	心血管疾患とその関連疾患の治療
DE10066408B4 (de) *	2000-03-24	2010-03-18	3M Espe Dental Ag	Verwendung feinkörniger Pulver für supragingivales Pulverstrahlen
CA2311734C (en) *	2000-04-12	2011-03-08	Bristol-Myers Squibb Company	Flash-melt oral dosage formulation
KR100659644B1 (ko)	2000-06-22	2006-12-21	노파르티스 아게	고형 발사르탄 약제학적 조성물
AU2005200815B2 (en) *	2000-06-22	2008-01-17	Novartis Ag	Solid valsartan pharmaceutical compositions
US20020132839A1 (en) *	2000-06-22	2002-09-19	Ganter Sabina Maria	Tablet formulations comprising valsartan
PE20020613A1 (es)	2000-07-19	2002-08-07	Novartis Ag	Sales de (s)-n-(1-carboxi-2-metil-prop-1-il)-n-pentanoil-n-[2'-(1h-tetrazol-5-il)-bifenil-4-ilmetil]-amina como antagonista del receptor at1
PE20020617A1 (es) *	2000-08-22	2002-08-05	Novartis Ag	Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
US20060089389A1 (en)	2000-08-22	2006-04-27	Malcolm Allison	Combination
US8168616B1 (en)	2000-11-17	2012-05-01	Novartis Ag	Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
EP1413315A4 (en) *	2001-08-03	2006-08-16	Takeda Pharmaceutical	DRUGS WITH CONTINUOUS RELEASE
GB0209265D0 (en) *	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
EG24716A (en)	2002-05-17	2010-06-07	Novartis Ag	Combination of organic compounds
DE10230272A1 (de) *	2002-07-05	2004-01-22	Solvay Pharmaceuticals Gmbh	AT1-Rezeptorantagonisten zur Prävention von Folgeschlaganfällen
EP1382334A1 (en) *	2002-07-11	2004-01-21	Université de Picardie Jules Verne	Use of angiotensin II AT1-receptor blockers (ARB), alone or combined with thiazide or angiotensin II for the treatment of stroke
US7199144B2 (en) *	2003-04-21	2007-04-03	Teva Pharmaceuticals Industries, Ltd.	Process for the preparation of valsartan and intermediates thereof
EP1950204A1 (en)	2003-03-17	2008-07-30	Teva Pharmaceutical Industries Ltd.	Amorphous form of valsartan
CA2519490A1 (en) *	2003-03-17	2004-09-30	Teva Pharmaceutical Industries Ltd	Polymorphis of valsartan
EP1556363A2 (en) *	2003-04-21	2005-07-27	Teva Pharmaceutical Industries Limited	Process for the preparation of valsartan and intermediates thereof
WO2004094392A1 (en) *	2003-04-21	2004-11-04	Teva Pharmaceutical Industries Ltd.	Process for the preparation of valsartan
JP4505859B2 (ja) *	2003-08-08	2010-07-21	味の素株式会社	ナテグリニド含有製剤
EA008063B1 (ru) *	2003-11-03	2007-02-27	Зентива А.С.	Рецептура, содержащая валсартан (valsartan)
GB0325605D0 (en) *	2003-11-03	2003-12-10	Novartis Ag	Combination of organic compounds
JP2005187793A (ja) *	2003-12-24	2005-07-14	Rohm & Haas Electronic Materials Llc	改良された接着剤
WO2005082329A2 (en) *	2004-02-19	2005-09-09	Ranbaxy Laboratories Limited	Process for the preparation of solid dosage forms of valsartan and hydrochlorthiazide
WO2005089720A1 (en) *	2004-03-10	2005-09-29	Ranbaxy Laboratories Limited	Valsartan tablets and the process for the preparation thereof
WO2006029056A1 (en)	2004-09-02	2006-03-16	Teva Pharmaceutical Industries Ltd.	Preparation of olmesartan medoxomil
EP2801354B1 (en) *	2004-10-08	2017-02-08	Forward Pharma A/S	Controlled release pharmaceutical compositions comprising a fumaric acid ester
ATE478564T1 (de) *	2004-10-15	2010-09-15	Suedzucker Ag	Verbessertes trommelcoating-verfahren
EP1674080A1 (en) *	2004-12-24	2006-06-28	KRKA, D.D., Novo Mesto	Solid pharmaceutical composition comprising valsartan
EP1833464A1 (en) *	2004-12-24	2007-09-19	KRKA, tovarna zdravil, d.d., Novo mesto	Solid pharmaceutical composition comprising valsartan
FR2882260A1 (fr) *	2005-02-21	2006-08-25	Flamel Technologies Sa	Forme pharmaceutique orale multimicroparticulaire a liberation modifiee d'antagonistes des recepteurs de l'angiotensine ii
EP2174658A1 (en) *	2005-05-31	2010-04-14	Mylan Laboratories, Inc	Compositions comprising nebivolol
EP1812411A2 (en) *	2005-07-05	2007-08-01	Teva Pharmaceutical Industries Ltd.	Process for preparing valsartan
GB0513888D0 (en) *	2005-07-06	2005-08-10	Btg Int Ltd	Core 2 GLCNAC-T Inhibitors II
WO2007052307A2 (en) *	2005-10-31	2007-05-10	Lupin Limited	Stable solid oral dosage forms of valsartan
RU2309732C1 (ru)	2006-03-13	2007-11-10	Олег Ильич Эпштейн	Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
WO2007112288A2 (en) *	2006-03-23	2007-10-04	Mount Sinai School Of Medicine	Cardiovascular composition and use the same for the treatment of alzheimers disease
JP5687425B2 (ja)	2006-06-06	2015-03-18	オレグイリッチエプシュテイン	肥満、真性糖尿病及び耐糖能異常を伴う疾患の治療用薬剤
WO2008035364A2 (en) *	2006-06-23	2008-03-27	Usv Limited	Process for the preparation of micronized valsartan
GB0612540D0 (en)	2006-06-23	2006-08-02	Novartis Ag	Galenical formulations of organic compounds
PE20081364A1 (es) *	2006-09-04	2008-12-04	Novartis Ag	Composicion farmaceutica que comprende valsartan
EP1897537A1 (en) *	2006-09-04	2008-03-12	Novartis AG	Composition comprising an angiotensin II receptor antagonist
KR100963389B1 (ko) *	2006-10-30	2010-06-14	한올바이오파마주식회사	시간차로 방출되는 치아자이드계 화합물과 안지오텐신―ⅱ―수용체 차단제를 포함하는 약학적 조성물
WO2008064338A2 (en) *	2006-11-22	2008-05-29	Rubicon Research Pvt. Ltd.	Valsartan formulation for pulsatile delivery
EP2139473A1 (en) *	2007-03-29	2010-01-06	Alembic Limited	Valsartan tablet formulations
TR200703568A1 (tr)	2007-05-24	2008-07-21	Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket�	Valsartan formülasyonları
RU2471356C2 (ru) *	2007-07-31	2013-01-10	Карджилл, Инкорпорейтед	Декстроза для прямого прессования
GB0715628D0 (en) *	2007-08-10	2007-09-19	Generics Uk Ltd	Solid valsartan composition
CN101396366B (zh) *	2007-09-25	2010-10-13	浙江华海药业股份有限公司	含缬沙坦的固体口服制剂及其制备方法
AU2008309058B2 (en) *	2007-09-28	2012-08-09	Novartis Ag	Galenical formulations of Aliskiren and Valsartan
EP2197416A1 (en) *	2007-10-09	2010-06-23	Novartis Ag	Pharmaceutical formulation of valsartan
PL3067043T3 (pl)	2007-11-06	2023-05-08	Novartis Ag	Kompozycje farmaceutyczne oparte na superstrukturach antagonisty/blokera receptora angiotensyny (arb) i inhibitora obojętnej endopeptydazy (nep)
EP2067470A1 (en) *	2007-12-03	2009-06-10	Laboratorios Lesvi, S.L.	Pharmaceutical compositions containing valsartan and process for its preparation
AU2008344891A1 (en) *	2007-12-31	2009-07-09	Lupin Limited	Pharmaceutical compositions of amlodipine and valsartan
US20110028526A1 (en) *	2008-02-28	2011-02-03	Amol Matharu	Valsartan solid oral dosage forms and methods of making such formulations
US20090226516A1 (en) *	2008-03-04	2009-09-10	Pharma Pass Ii Llc	Sartan compositions
US20090226515A1 (en) *	2008-03-04	2009-09-10	Pharma Pass Ii Llc	Statin compositions
KR101209319B1 (ko) *	2008-04-29	2012-12-06	한올바이오파마주식회사	안지오텐신-ⅱ-수용체 차단제를 포함하는 약제학적 제제
WO2009149493A1 (en) *	2008-06-09	2009-12-17	Dimerix Bioscience Pty Ltd	Novel receptor hetero-dimers/-oligomers
KR101033975B1 (ko) *	2008-10-10	2011-05-11	이희엽	직접압축법을 이용한 발사르탄 함유 고형 경구 제형의 제조방법 및 이에 따라 제조된 고형 경구 제형
DE102008051783A1 (de)	2008-10-17	2010-04-22	Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg	Valsartan enthaltende Tablette
US9387249B2 (en)	2008-12-23	2016-07-12	Takeda Pharmaceutical Company Limited	Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone
WO2010104485A2 (en)	2009-03-11	2010-09-16	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Valsartan formulations
KR101084783B1 (ko) *	2009-09-01	2011-11-22	삼성에스디아이 주식회사	이차 전지 및 그의 제조 방법
WO2011027021A1 (en) *	2009-09-01	2011-03-10	Orion Corporation	A method for the treatment of hypertension
ES2364011B1 (es)	2009-11-20	2013-01-24	Gp Pharm, S.A.	Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
CN101897675B (zh) *	2010-02-10	2012-11-21	温士顿医药股份有限公司	含有凡尔沙坦或其药学上可接受的盐的固体剂型口服医药组成物
SI2536396T1 (sl)	2010-02-16	2017-01-31	KRKA, tovarna zdravil, d.d.,Novo mesto	Postopek za pripravo oralnih trdnih odmernih oblik, ki obsegajo valsartan
AR083417A1 (es)	2010-10-14	2013-02-21	Novartis Ag	Composiciones farmaceuticas que contienen un dgat1 inhibidor
JP5882796B2 (ja)	2011-03-31	2016-03-09	キヤノン株式会社	振動体の駆動方法、振動装置、該振動装置を有する駆動装置、及び光学機器
GB201116993D0 (en) *	2011-10-03	2011-11-16	Ems Sa	Pharmaceutical compositions of antihypertensives
KR20140108652A (ko)	2011-12-26	2014-09-12	노파르티스 아게	정제 및 건식-코팅된 작용제
WO2013098578A1 (en)	2011-12-31	2013-07-04	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Immediate release pharmaceutical composition of valsartan hydrochlorothiazide
WO2013098576A1 (en)	2011-12-31	2013-07-04	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Immediate release pharmaceutical composition of valsartan
JP6018420B2 (ja) *	2012-06-05	2016-11-02	ニプロ株式会社	アンジオテンシンｉｉ受容体拮抗薬およびサイアザイド系利尿薬を含む医薬組成物
WO2014038895A1 (ko) *	2012-09-06	2014-03-13	한국콜마주식회사	발사르탄 함유 고형 경구제형 및 그 제조방법
JP2014062064A (ja) *	2012-09-21	2014-04-10	Ohara Yakuhin Kogyo Kk	バルサルタン含有錠剤の製造方法
JP6238831B2 (ja) *	2014-04-25	2017-11-29	沢井製薬株式会社	バルサルタン含有錠剤及びその製造方法
JP6141472B2 (ja) *	2016-03-02	2017-06-07	大原薬品工業株式会社	バルサルタン含有錠剤の製造方法
WO2018002673A1 (en)	2016-07-01	2018-01-04	N4 Pharma Uk Limited	Novel formulations of angiotensin ii receptor antagonists
EP3807898A1 (en)	2018-06-14	2021-04-21	AstraZeneca UK Limited	Methods for treatment of hypertension with an angiotensin ii receptor blocker pharmaceutical composition
EP4295839A1 (en)	2022-06-20	2023-12-27	KRKA, d.d., Novo mesto	Combination of valsartan and indapamide

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3200039A (en)	1962-05-28	1965-08-10	Pfizer & Co C	Non-granulated tablets with 20% sorbitol in a particle size of from about 100mu to about 2000mu
GB1422176A (en)	1973-05-05	1976-01-21	Beecham Group Ltd	Pharmaceutical tablets
AU528098B2 (en)	1978-11-16	1983-04-14	Beecham Group Plc	Analgesic tablet
US4353887A (en)	1979-08-16	1982-10-12	Ciba-Geigy Corporation	Divisible tablet having controlled and delayed release of the active substance
US4238485A (en) *	1979-10-29	1980-12-09	Merck & Co., Inc.	Novel pharmaceutical compositions
EP0070127A3 (en)	1981-07-10	1983-08-17	Beecham Group Plc	Tablets
US4543359A (en) *	1982-10-01	1985-09-24	Eaton Laboratories, Inc.	Treating cardiac arrhythmias with dantrolene sodium
HU187215B (en) *	1983-01-26	1985-11-28	Egyt Gyogyszervegyeszeti Gyar	Method for producing pharmaceutical product of high actor content and prolonged effect
US4609675A (en) *	1984-08-17	1986-09-02	The Upjohn Company	Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4743612A (en) *	1986-10-17	1988-05-10	Berlex Laboratories, Inc.	Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-(4-(2-methyl-1H-imidazol-1-yl)benzoyl)-2H-imidazol-2-one, composition containing them, and method of using them to treat cardiac failure
DE3705055A1 (de) *	1987-02-18	1988-09-01	Boehringer Ingelheim Kg	Verwendung von 2-(3-fluor-4-methylphenylimino)-imidazolidin zur behandlung der koronaren herzkrankheit
JP2518854B2 (ja) *	1987-06-19	1996-07-31	旭化成工業株式会社	固形製剤の製法
DE3739779A1 (de) *	1987-11-24	1989-06-08	Beiersdorf Ag	Pharmazeutische praeparate
SE506179C2 (sv) *	1989-01-23	1997-11-17	Ciba Geigy Ag	Farmaceutisk lågkomposition av benazepril och ett tiaziddiuretikum
GB8909793D0 (en)	1989-04-28	1989-06-14	Beecham Group Plc	Pharmaceutical formulation
DE122007000050I1 (de) *	1990-02-19	2007-11-08	Novartis Ag	Acylverbindungen
WO1992005786A1 (en) *	1990-09-28	1992-04-16	Merck & Co., Inc.	Ibuprofen-diuretic combinations
DE69331839T2 (de) *	1992-01-29	2002-12-12	Takeda Chemical Industries, Ltd.	Schnellösliche Tablette und ihre Herstellung
ZA931063B (en)	1992-02-17	1993-09-23	Ciba Geigy	Treatment of glaucoma.
US5395627A (en) *	1992-09-04	1995-03-07	Akzo N.V.	Pharmaceutical granulate
IT1255522B (it) *	1992-09-24	1995-11-09	Ubaldo Conte	Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
AU5449194A (en)	1992-10-26	1994-05-24	Merck & Co., Inc.	Combinations of angiotensin-ii receptor antagonists and diuretics
AU5745394A (en)	1992-12-30	1994-08-15	Fmc Corporation	Readily available konjac glucomannan sustained release excipient
JP3057471B2 (ja) *	1993-06-07	2000-06-26	武田薬品工業株式会社	アンジオテンシンｉｉ介在性諸疾患の予防または治療剤
US5464854A (en)	1993-11-11	1995-11-07	Depadova; Anathony S.	Method of modifying ovarian hormone-regulated AT1 receptor activity as treatment of incapacitating symptom(s) of P.M.S.
AT401871B (de) *	1994-01-28	1996-12-27	Gebro Broschek Gmbh	Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
JP3534130B2 (ja) *	1994-03-01	2004-06-07	旭化成ケミカルズ株式会社	医薬品組成物
GB9404010D0 (en) *	1994-03-02	1994-04-20	Opt Tel Services Limited	Telephone dialling monitoring and route selecting apparatus
CN1143908A (zh) *	1994-03-17	1997-02-26	西巴-盖尔基股份公司	利用哇尔沙通(valsartan)治疗糖尿病型肾病
GB9408117D0 (en)	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
DE19502065C2 (de) *	1995-01-14	1996-05-02	Prophyta Biolog Pflanzenschutz	Pilzisolat mit fungizider Wirkung
US5994348A (en) *	1995-06-07	1999-11-30	Sanofi	Pharmaceutical compositions containing irbesartan
FR2735365B1 (fr) *	1995-06-14	1997-09-05	Sanofi Sa	Utilisation d'un antagoniste de l'angiotensine ii et d'un derive du benzofurane pour la preparation d'un medicament utile dans le traitement des affections cardiovasculaires
GB9613470D0 (en) *	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
JP2011123241A (ja) *	2009-12-10	2011-06-23	Canon Inc	撮影システム

1996
- 1996-06-27 GB GBGB9613470.5A patent/GB9613470D0/en active Pending
1997
- 1997-06-14 MY MYPI20093392A patent/MY156312A/en unknown
- 1997-06-14 MY MYPI20041863A patent/MY146868A/en unknown
- 1997-06-14 MY MYPI97002679A patent/MY123149A/en unknown
- 1997-06-18 KR KR1020097017936A patent/KR101161283B1/ko not_active IP Right Cessation
- 1997-06-18 HU HU0203374A patent/HU229134B1/hu not_active IP Right Cessation
- 1997-06-18 CA CA002259148A patent/CA2259148C/en not_active Expired - Fee Related
- 1997-06-18 BR BR9709956A patent/BR9709956A/pt not_active Application Discontinuation
- 1997-06-18 DK DK03027840T patent/DK1410797T3/da active
- 1997-06-18 DE DE69739642T patent/DE69739642D1/de not_active Expired - Lifetime
- 1997-06-18 AT AT03027840T patent/ATE371449T1/de active
- 1997-06-18 AT AT06126819T patent/ATE446749T1/de active
- 1997-06-18 CN CN031466788A patent/CN1475207B/zh not_active Expired - Lifetime
- 1997-06-18 ES ES03027840T patent/ES2290400T3/es not_active Expired - Lifetime
- 1997-06-18 CZ CZ0426998A patent/CZ296850B6/cs not_active IP Right Cessation
- 1997-06-18 DE DE69730834T patent/DE69730834T2/de not_active Expired - Lifetime
- 1997-06-18 CN CN2006100999105A patent/CN1951372B/zh not_active Expired - Lifetime
- 1997-06-18 AT AT97929209T patent/ATE276750T1/de active
- 1997-06-18 ES ES06126819T patent/ES2335683T3/es not_active Expired - Lifetime
- 1997-06-18 EP EP06126838A patent/EP1767207A3/en not_active Withdrawn
- 1997-06-18 KR KR1019980710521A patent/KR100618038B1/ko not_active IP Right Cessation
- 1997-06-18 EP EP06126829A patent/EP1774967A1/en not_active Withdrawn
- 1997-06-18 TR TR1998/02698T patent/TR199802698T2/xx unknown
- 1997-06-18 DK DK97929209T patent/DK0914119T3/da active
- 1997-06-18 JP JP10502269A patent/JP2000506540A/ja active Pending
- 1997-06-18 EP EP97929209A patent/EP0914119B1/en not_active Expired - Lifetime
- 1997-06-18 PL PL97363524A patent/PL188271B1/pl unknown
- 1997-06-18 PT PT06126819T patent/PT1767206E/pt unknown
- 1997-06-18 SI SI9730686T patent/SI0914119T1/xx unknown
- 1997-06-18 CA CA2673462A patent/CA2673462C/en not_active Expired - Fee Related
- 1997-06-18 EP EP03027840A patent/EP1410797B1/en not_active Revoked
- 1997-06-18 KR KR1020117011286A patent/KR101208430B1/ko not_active IP Right Cessation
- 1997-06-18 KR KR1020067011260A patent/KR20060079260A/ko not_active Application Discontinuation
- 1997-06-18 DK DK06126819.9T patent/DK1767206T3/da active
- 1997-06-18 ES ES97929209T patent/ES2231873T3/es not_active Expired - Lifetime
- 1997-06-18 CN CNB971958912A patent/CN1133427C/zh not_active Expired - Lifetime
- 1997-06-18 WO PCT/EP1997/003172 patent/WO1997049394A2/en active Search and Examination
- 1997-06-18 SK SK1784-98A patent/SK285902B6/sk not_active IP Right Cessation
- 1997-06-18 RU RU99101056/14A patent/RU2203054C2/ru active IP Right Maintenance
- 1997-06-18 NZ NZ333385A patent/NZ333385A/xx not_active IP Right Cessation
- 1997-06-18 SI SI9730773T patent/SI1410797T1/sl unknown
- 1997-06-18 RU RU99101056/63D patent/RU2294743C2/ru not_active IP Right Cessation
- 1997-06-18 PT PT97929209T patent/PT914119E/pt unknown
- 1997-06-18 PT PT03027840T patent/PT1410797E/pt unknown
- 1997-06-18 US US09/202,805 patent/US6294197B1/en not_active Expired - Lifetime
- 1997-06-18 EP EP09001681A patent/EP2055301A1/en not_active Withdrawn
- 1997-06-18 EP EP06126819A patent/EP1767206B1/en not_active Revoked
- 1997-06-18 KR KR1020087000538A patent/KR20080014149A/ko active Search and Examination
- 1997-06-18 KR KR1020057015071A patent/KR100792389B1/ko not_active IP Right Cessation
- 1997-06-18 DE DE69738089T patent/DE69738089T2/de not_active Expired - Lifetime
- 1997-06-18 PL PL97330709A patent/PL188233B1/pl not_active IP Right Cessation
- 1997-06-18 EP EP06126834A patent/EP1776953A1/en not_active Withdrawn
- 1997-06-18 IL IL12756497A patent/IL127564A0/xx unknown
- 1997-06-23 CO CO97034775A patent/CO4870755A1/es unknown
- 1997-06-24 PE PE1997000539A patent/PE87498A1/es not_active IP Right Cessation
- 1997-06-25 AR ARP970102790A patent/AR008618A1/es active IP Right Grant
- 1997-06-26 ID IDP972207A patent/ID17553A/id unknown
- 1997-06-26 ZA ZA9705673A patent/ZA975673B/xx unknown
- 1997-09-09 TW TW086113018A patent/TW473394B/zh not_active IP Right Cessation
1998
- 1998-12-22 NO NO19986056A patent/NO317181B1/no not_active IP Right Cessation
1999
- 1999-11-09 HK HK99105148A patent/HK1019858A1/xx not_active IP Right Cessation
2001
- 2001-08-01 US US09/920,159 patent/US6485745B1/en not_active Expired - Fee Related
2002
- 2002-09-20 US US10/251,009 patent/US6858228B2/en not_active Expired - Fee Related
2003
- 2003-01-23 JP JP2003014987A patent/JP2003231634A/ja not_active Withdrawn
- 2003-02-21 NZ NZ524346A patent/NZ524346A/en not_active IP Right Cessation
2004
- 2004-03-26 NO NO20041287A patent/NO331739B1/no not_active IP Right Cessation
- 2004-05-25 HK HK04103718.1A patent/HK1060700A1/xx not_active IP Right Cessation
2006
- 2006-03-21 CY CY0600007A patent/CY2553B1/xx unknown
2007
- 2007-01-10 RU RU2007100200/15A patent/RU2453306C2/ru not_active IP Right Cessation
- 2007-02-06 AR ARP070100474A patent/AR059324A2/es not_active Application Discontinuation
- 2007-06-28 JP JP2007170267A patent/JP4969338B2/ja not_active Expired - Lifetime
2008
- 2008-11-17 IL IL195339A patent/IL195339A0/en unknown
2009
- 2009-04-27 RU RU2009115778/15A patent/RU2009115778A/ru unknown
2011
- 2011-12-09 JP JP2011270429A patent/JP2012051948A/ja not_active Withdrawn
2013
- 2013-03-26 RU RU2013113610/15A patent/RU2013113610A/ru not_active Application Discontinuation
- 2013-10-25 JP JP2013221985A patent/JP2014012747A/ja active Pending

Also Published As

Publication number	Publication date
PT1767206E (pt)	2010-01-27
PT914119E (pt)	2005-02-28
BR9709956A (pt)	1999-08-10
HK1019858A1 (en)	2000-06-09
WO1997049394A2 (en)	1997-12-31
HK1060700A1 (en)	2004-08-20
DE69730834T2 (de)	2005-10-06
NZ524346A (en)	2004-09-24
PL188233B1 (pl)	2004-12-31
AU3340297A (en)	1998-01-14
NO317181B1 (no)	2004-09-06
CZ426998A3 (cs)	1999-03-17
HUP0203374A3 (en)	2004-06-28
SK285902B6 (sk)	2007-10-04
EP1774967A1 (en)	2007-04-18
MY123149A (en)	2006-05-31
CN1475207A (zh)	2004-02-18
PT1410797E (pt)	2007-12-03
RU2013113610A (ru)	2014-10-10
SI0914119T1 (en)	2005-04-30
EP0914119A3 (en)	2002-03-06
MY156312A (en)	2016-01-29
JP2014012747A (ja)	2014-01-23
ES2231873T3 (es)	2005-05-16
EP0914119A2 (en)	1999-05-12
PL188271B1 (pl)	2005-01-31
DK0914119T3 (da)	2005-01-31
CO4870755A1 (es)	1999-12-27
KR20080014149A (ko)	2008-02-13
SI1410797T1 (sl)	2008-08-31
NO986056D0 (no)	1998-12-22
ATE446749T1 (de)	2009-11-15
CN1133427C (zh)	2004-01-07
KR20000022111A (ko)	2000-04-25
WO1997049394A3 (en)	2001-12-20
DK1410797T3 (da)	2007-10-15
AR008618A1 (es)	2000-02-09
CZ296850B6 (cs)	2006-07-12
RU2453306C2 (ru)	2012-06-20
IL195339A0 (en)	2009-08-03
CA2673462A1 (en)	1997-12-31
KR100618038B1 (ko)	2006-11-30
EP1767206B1 (en)	2009-10-28
CN1951372A (zh)	2007-04-25
KR20090099020A (ko)	2009-09-18
EP1767207A3 (en)	2007-04-18
NO331739B1 (no)	2012-03-12
ES2290400T3 (es)	2008-02-16
JP2003231634A (ja)	2003-08-19
KR20060079260A (ko)	2006-07-05
GB9613470D0 (en)	1996-08-28
EP1767206A2 (en)	2007-03-28
RU2203054C2 (ru)	2003-04-27
EP2055301A1 (en)	2009-05-06
EP1410797A1 (en)	2004-04-21
SK178498A3 (en)	1999-06-11
KR101161283B1 (ko)	2012-07-02
PL330709A1 (en)	1999-05-24
EP0914119B1 (en)	2004-09-22
US20030035832A1 (en)	2003-02-20
ATE371449T1 (de)	2007-09-15
JP2012051948A (ja)	2012-03-15
DE69739642D1 (de)	2009-12-10
MY146868A (en)	2012-09-28
KR101208430B1 (ko)	2012-12-05
JP4969338B2 (ja)	2012-07-04
AU724998B2 (en)	2000-10-05
CN1232394A (zh)	1999-10-20
TW473394B (en)	2002-01-21
CA2673462C (en)	2011-10-04
KR20110063587A (ko)	2011-06-10
NZ333385A (en)	2000-09-29
DE69738089D1 (de)	2007-10-11
NO20041287L (no)	2004-03-26
CN1951372B (zh)	2011-03-23
DK1767206T3 (da)	2010-01-25
ZA975673B (en)	1997-12-29
ID17553A (id)	1998-01-08
AR059324A2 (es)	2008-03-26
ATE276750T1 (de)	2004-10-15
RU2294743C2 (ru)	2007-03-10
CY2553B1 (en)	2008-07-02
CA2259148C (en)	2009-09-29
DE69730834D1 (de)	2004-10-28
PE87498A1 (es)	1998-12-21
KR100792389B1 (ko)	2008-01-08
US6485745B1 (en)	2002-11-26
RU2009115778A (ru)	2010-11-10
CA2259148A1 (en)	1997-12-31
EP1767206A3 (en)	2007-04-18
DE69738089T2 (de)	2008-05-21
CN1475207B (zh)	2010-09-29
HUP0203374A2 (hu)	2004-05-28
RU2007100200A (ru)	2008-07-20
JP2007238637A (ja)	2007-09-20
TR199802698T2 (xx)	1999-04-21
HU229134B1 (en)	2013-08-28
JP2000506540A (ja)	2000-05-30
ES2335683T3 (es)	2010-03-31
US6294197B1 (en)	2001-09-25
EP1767207A2 (en)	2007-03-28
IL127564A0 (en)	1999-10-28
US6858228B2 (en)	2005-02-22
EP1410797B1 (en)	2007-08-29
EP1776953A1 (en)	2007-04-25
KR20050092054A (ko)	2005-09-16

Publication	Publication Date	Title
NO986056D0 (no)	1998-12-22	Faste orale doseringsformer av valsartan
LU90115B1 (fr)	1997-09-10	Formulation orale de 2-méthyl-thiéno-benzodiazépine
NO962490D0 (no)	1996-06-12	Orale formuleringer av S(+)-ibuprofen
NO20001775D0 (no)	2000-04-06	Munnhygienepreparat til behandling av halitose
DK0747050T3 (da)	2003-12-15	Farmaceutiske sammensætninger indeholdende irbesartan
DE59712959D1 (de)	2008-09-25	Orale pharmazeutische zubereitung enthaltend ibandronat
MA26673A1 (fr)	2004-12-20	Composes pharmaceutiques
NO962491D0 (no)	1996-06-12	Orale formuleringer av S(+)-etodolac
NO20001585L (no)	2000-03-27	Orale sammensetninger av levosimendan
EP0923564A4 (en)	1999-12-08	Pharmaceutical compounds
NO991148D0 (no)	1999-03-10	Fremstilling av 1-butyl-4-piperidinyl-metylamin
NO981798D0 (no)	1998-04-22	FremgangsmÕte for fremstilling av faste legemiddelformer
NO980501D0 (no)	1998-02-05	Fôring av rör
AU724998C (en)	2013-05-23	Solid oral dosage forms of valsartan
NO974458D0 (no)	1997-09-26	Fremstilling av cis-4-O-beskyttede-2-cyklopentenolderivater
FI952808A0 (fi)	1995-06-07	Rensapparat foer invaendig rengoering av luftkanaler med rektangulaert tvaersmitt
FIU950441U0 (fi)	1995-10-13	Glasfoeremaol med bihang av metalltraod
FI955924A0 (fi)	1995-12-11	Rengoering av skivvaermevaexlare med effektultraljud
BR9612652A (pt)	1999-07-20	Forma de administração farmacêutica
FI945152A0 (fi)	1994-11-01	Foerfarande foer kontrollering av en temperaturgivares funktion i en uppsamlingsanordning foer maetuppgifter
NO965176D0 (no)	1996-12-04	Kapsel med innhold av munn-skyllevann

Legal Events

Date	Code	Title	Description
2015-01-26	MM1K	Lapsed by not paying the annual fees